1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Chi, S.-W. Park, K.-H. Suk, J.-E. Olivera, B.M. McIntosh, J.M. Han, K.-H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C5 H9 N O3 131.130 n 4-HYDROXYPROLINE HYDROXYPROLINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 278 42208 42213 10.1074/jbc.M303342200 12900418 Solution Conformation of alphaA-conotoxin EIVA, a Potent Neuromuscular Nicotinic Acetylcholine Receptor Antagonist from Conus ermineus 2003 10.2210/pdb1pqr/pdb pdb_00001pqr 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 3105.495 Alpha-A-conotoxin EIVA 1 syn polymer no yes GCCGPY(HYP)NAACH(HYP)CGCKVGR(HYP)(HYP)YCDR(HYP)SGG(NH2) GCCGPYPNAACHPCGCKVGRPPYCDRPSGGX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_ref_seq_dif struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-11-04 1 1 2008-04-29 1 2 2011-07-13 1 3 2022-03-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_ref_seq_dif.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id RCSB Y PDBJ 2003-06-18 REL REL This sequence occurs naturally in Conus ermineus venom. sample This structure was determined using standard 2D homonuclear techniques. back calculated data agree with experimental NOESY spectrum 50 18 2D NOESY 2D TOCSY DQF-COSY PE-COSY 0.01 3.6 1 atm 288 K The structures are based on a total of 388 NOE-derived distance constraints, 11 dihedral angle restraints distance geometry, molecular dynamics 5 closest to the average 5mM alpha-A-conotoxin EIVA 90% H2O/10% D2O collection VNMR 6.1B processing Felix 98.0 refinement Discover 2.98 600 Varian INOVA GLY 1 n 1 GLY 1 A CYS 2 n 2 CYS 2 A CYS 3 n 3 CYS 3 A GLY 4 n 4 GLY 4 A PRO 5 n 5 PRO 5 A TYR 6 n 6 TYR 6 A HYP 7 n 7 HYP 7 A ASN 8 n 8 ASN 8 A ALA 9 n 9 ALA 9 A ALA 10 n 10 ALA 10 A CYS 11 n 11 CYS 11 A HIS 12 n 12 HIS 12 A HYP 13 n 13 HYP 13 A CYS 14 n 14 CYS 14 A GLY 15 n 15 GLY 15 A CYS 16 n 16 CYS 16 A LYS 17 n 17 LYS 17 A VAL 18 n 18 VAL 18 A GLY 19 n 19 GLY 19 A ARG 20 n 20 ARG 20 A HYP 21 n 21 HYP 21 A HYP 22 n 22 HYP 22 A TYR 23 n 23 TYR 23 A CYS 24 n 24 CYS 24 A ASP 25 n 25 ASP 25 A ARG 26 n 26 ARG 26 A HYP 27 n 27 HYP 27 A SER 28 n 28 SER 28 A GLY 29 n 29 GLY 29 A GLY 30 n 30 GLY 30 A NH2 31 n 31 NH2 31 A author_defined_assembly 1 monomeric A HYP 7 4-HYDROXYPROLINE A HYP 7 PRO A HYP 13 4-HYDROXYPROLINE A HYP 13 PRO A HYP 21 4-HYDROXYPROLINE A HYP 21 PRO A HYP 22 4-HYDROXYPROLINE A HYP 22 PRO A HYP 27 4-HYDROXYPROLINE A HYP 27 PRO 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 3 A A O HB3 HYP ARG 22 26 1.27 6 A A SG HG3 CYS ARG 14 20 1.45 7 A A O HB3 HYP ARG 22 26 1.42 8 A A O HB3 HYP ARG 22 26 1.48 13 A A HB3 HD22 ARG HYP 26 27 1.26 16 A A HB3 HD22 ARG HYP 20 21 1.20 16 A A HB3 HD23 ARG HYP 26 27 1.32 17 A A HB3 HD23 ARG HYP 26 27 0.95 1 8.71 1.20 111.50 120.21 A A A CB CA C CYS CYS CYS 2 2 2 N 1 8.03 1.30 111.50 119.53 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 1 3.68 0.50 120.30 123.98 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 1 -6.14 0.90 118.30 112.16 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 1 3.74 0.50 120.30 124.04 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 2 8.14 1.20 111.50 119.64 A A A CB CA C CYS CYS CYS 2 2 2 N 2 7.96 1.30 111.50 119.46 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 2 3.73 0.50 120.30 124.03 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 2 -5.96 0.90 118.30 112.34 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 2 3.70 0.50 120.30 124.00 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 3 7.40 1.20 111.50 118.90 A A A CB CA C CYS CYS CYS 11 11 11 N 3 7.86 1.30 111.50 119.36 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 3 3.68 0.50 120.30 123.98 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 3 6.13 0.90 118.30 124.43 A A A CB CG OD1 ASP ASP ASP 25 25 25 N 3 -6.82 0.90 118.30 111.48 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 3 3.70 0.50 120.30 124.00 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 4 7.56 1.20 111.50 119.06 A A A CB CA C CYS CYS CYS 2 2 2 N 4 8.73 1.20 111.50 120.23 A A A CB CA C CYS CYS CYS 11 11 11 N 4 8.10 1.30 111.50 119.60 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 4 4.05 0.50 120.30 124.35 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 4 -5.94 0.90 118.30 112.36 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 4 3.72 0.50 120.30 124.02 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 5 8.08 1.30 111.50 119.58 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 5 3.64 0.50 120.30 123.94 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 5 -6.07 0.90 118.30 112.23 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 5 3.61 0.50 120.30 123.91 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 6 8.48 1.20 111.50 119.98 A A A CB CA C CYS CYS CYS 2 2 2 N 6 7.96 1.30 111.50 119.46 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 6 3.67 0.50 120.30 123.97 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 6 -6.09 0.90 118.30 112.21 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 6 3.65 0.50 120.30 123.95 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 7 7.60 1.20 111.50 119.10 A A A CB CA C CYS CYS CYS 2 2 2 N 7 8.00 1.30 111.50 119.50 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 7 3.78 0.50 120.30 124.08 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 7 -6.00 0.90 118.30 112.30 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 7 3.75 0.50 120.30 124.05 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 8 8.07 1.30 111.50 119.57 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 8 3.88 0.50 120.30 124.18 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 8 -6.15 0.90 118.30 112.15 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 8 3.73 0.50 120.30 124.03 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 9 8.07 1.30 111.50 119.57 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 9 3.72 0.50 120.30 124.02 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 9 -6.03 0.90 118.30 112.27 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 9 3.66 0.50 120.30 123.96 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 10 7.98 1.30 111.50 119.48 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 10 3.89 0.50 120.30 124.19 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 10 -6.07 0.90 118.30 112.23 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 10 3.70 0.50 120.30 124.00 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 11 8.02 1.30 111.50 119.52 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 11 3.86 0.50 120.30 124.16 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 11 -6.12 0.90 118.30 112.18 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 11 3.71 0.50 120.30 124.01 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 12 8.04 1.30 111.50 119.54 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 12 3.57 0.50 120.30 123.87 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 12 -5.66 0.90 118.30 112.64 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 12 3.65 0.50 120.30 123.95 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 13 8.05 1.20 111.50 119.55 A A A CB CA C CYS CYS CYS 2 2 2 N 13 7.96 1.30 111.50 119.46 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 13 3.78 0.50 120.30 124.08 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 13 -6.00 0.90 118.30 112.30 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 13 3.69 0.50 120.30 123.99 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 14 8.06 1.30 111.50 119.56 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 14 3.81 0.50 120.30 124.11 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 14 -6.06 0.90 118.30 112.24 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 14 3.73 0.50 120.30 124.03 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 15 8.15 1.20 111.50 119.65 A A A CB CA C CYS CYS CYS 2 2 2 N 15 7.99 1.30 111.50 119.49 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 15 3.79 0.50 120.30 124.09 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 15 -5.80 0.90 118.30 112.50 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 15 3.72 0.50 120.30 124.02 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 16 7.94 1.30 111.50 119.44 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 16 -12.07 2.00 110.40 98.33 A A A CB CA C ARG ARG ARG 20 20 20 N 16 3.70 0.50 120.30 124.00 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 16 -6.01 0.90 118.30 112.29 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 16 3.71 0.50 120.30 124.01 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 17 8.36 1.20 111.50 119.86 A A A CB CA C CYS CYS CYS 2 2 2 N 17 7.97 1.30 111.50 119.47 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 17 3.71 0.50 120.30 124.01 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 17 -5.96 0.90 118.30 112.34 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 17 3.66 0.50 120.30 123.96 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 18 8.00 1.30 111.50 119.50 A A A ND1 CE1 NE2 HIS HIS HIS 12 12 12 N 18 3.81 0.50 120.30 124.11 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 18 -5.87 0.90 118.30 112.43 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 18 3.62 0.50 120.30 123.92 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 1 A A CG CD2 HIS HIS 12 12 0.055 0.009 1.354 1.409 N 2 A A CG CD2 HIS HIS 12 12 0.056 0.009 1.354 1.410 N 3 A A CG CD2 HIS HIS 12 12 0.055 0.009 1.354 1.409 N 4 A A CG CD2 HIS HIS 12 12 0.059 0.009 1.354 1.413 N 5 A A CG CD2 HIS HIS 12 12 0.056 0.009 1.354 1.410 N 6 A A CG CD2 HIS HIS 12 12 0.055 0.009 1.354 1.409 N 7 A A CG CD2 HIS HIS 12 12 0.054 0.009 1.354 1.408 N 8 A A CG CD2 HIS HIS 12 12 0.064 0.009 1.354 1.418 N 9 A A CG CD2 HIS HIS 12 12 0.055 0.009 1.354 1.409 N 10 A A CG CD2 HIS HIS 12 12 0.056 0.009 1.354 1.410 N 12 A A CG CD2 HIS HIS 12 12 0.055 0.009 1.354 1.409 N 13 A A CG CD2 HIS HIS 12 12 0.055 0.009 1.354 1.409 N 14 A A CG CD2 HIS HIS 12 12 0.055 0.009 1.354 1.409 N 15 A A CG CD2 HIS HIS 12 12 0.055 0.009 1.354 1.409 N 1 A CYS 2 -124.15 -121.34 1 A CYS 3 -150.77 -86.86 1 A HYP 7 37.25 -174.70 1 A ASN 8 -143.11 39.09 1 A ALA 9 -90.36 -92.00 1 A CYS 14 -116.87 56.07 1 A LYS 17 -80.53 -76.90 1 A HYP 21 -41.77 159.01 1 A HYP 27 -57.67 107.80 2 A CYS 2 -119.32 -123.04 2 A CYS 3 -150.75 -79.81 2 A HYP 7 20.76 -144.64 2 A ASN 8 -133.51 -52.15 2 A ALA 9 -71.33 -84.18 2 A LYS 17 -80.43 -71.21 2 A HYP 21 -48.45 163.60 2 A HYP 27 -50.53 107.77 3 A CYS 3 -133.29 -85.91 3 A ASN 8 -101.19 -76.07 3 A ALA 9 -90.56 -110.00 3 A CYS 11 57.82 82.34 3 A HYP 27 -47.09 102.16 3 A SER 28 -150.68 -83.55 4 A CYS 2 -99.19 -98.61 4 A CYS 3 -139.88 -108.61 4 A ASN 8 -85.99 -82.48 4 A ALA 9 -90.22 -92.03 4 A LYS 17 -85.52 -72.95 4 A HYP 27 -46.87 105.71 5 A CYS 2 -87.14 -107.99 5 A CYS 3 -150.74 -76.87 5 A ASN 8 -141.40 -111.10 5 A ALA 10 -111.79 71.98 5 A CYS 14 -116.63 74.20 5 A HYP 21 -38.84 160.64 5 A HYP 27 -57.80 102.84 6 A CYS 2 -124.39 -121.36 6 A CYS 3 -150.82 -80.83 6 A ASN 8 -152.99 -83.95 6 A ALA 9 -90.75 -93.72 6 A ALA 10 -107.41 54.19 6 A CYS 14 -114.56 54.86 6 A LYS 17 -79.80 -72.19 6 A HYP 21 -45.50 157.99 6 A HYP 27 -52.36 109.18 7 A CYS 2 -98.59 -110.39 7 A CYS 3 -150.45 -75.26 7 A ASN 8 -140.54 -82.14 7 A ALA 9 -90.71 -95.45 7 A CYS 14 -92.13 30.14 7 A ASP 25 -132.45 -38.44 7 A HYP 27 -53.03 103.18 8 A CYS 2 -81.54 -87.04 8 A CYS 3 -144.07 -95.86 8 A ALA 9 -90.26 40.43 8 A ALA 10 31.33 64.37 8 A CYS 14 -97.76 38.58 8 A LYS 17 -116.54 -74.72 8 A ASP 25 -134.98 -37.68 8 A HYP 27 -53.81 103.72 9 A CYS 2 -160.57 94.45 9 A TYR 6 -150.38 -46.21 9 A HYP 7 -77.85 -163.25 9 A ASN 8 -139.61 -53.46 9 A ALA 10 -90.73 53.36 9 A CYS 14 -108.80 64.89 9 A CYS 16 -90.60 -100.42 9 A LYS 17 164.60 -82.87 9 A HYP 21 -41.54 159.68 9 A HYP 27 -67.86 99.41 10 A CYS 2 -134.08 -88.99 10 A CYS 3 -137.28 -71.44 10 A ASN 8 -141.83 -72.60 10 A CYS 14 -87.85 30.31 10 A LYS 17 -108.09 -71.75 10 A HYP 21 -45.65 160.22 11 A CYS 3 -115.66 -80.88 11 A ALA 9 -90.51 55.50 11 A ALA 10 30.46 62.70 11 A HYP 21 -39.85 154.41 11 A HYP 27 -54.33 107.94 12 A CYS 2 -91.37 -81.49 12 A CYS 3 -149.21 -73.82 12 A ASN 8 -139.14 -85.70 12 A ALA 9 -90.73 -91.38 12 A ALA 10 -107.74 46.00 12 A CYS 14 -108.13 59.15 12 A HYP 21 -44.64 156.28 12 A HYP 27 -53.20 107.87 13 A CYS 2 -108.22 -118.01 13 A CYS 3 -150.68 -75.02 13 A LYS 17 -76.55 -70.75 13 A ARG 26 -76.31 -162.55 13 A HYP 27 -57.58 94.01 14 A CYS 2 -90.78 -71.36 14 A CYS 3 -137.37 -89.73 14 A ASN 8 -86.32 -82.94 14 A ALA 9 -90.47 -88.73 14 A HYP 21 -55.08 171.30 14 A HYP 27 -58.28 102.28 15 A CYS 2 -115.01 -121.09 15 A CYS 3 -150.83 -77.59 15 A TYR 6 -93.53 -75.55 15 A HYP 7 -70.99 -162.22 15 A ALA 9 -71.28 -83.28 15 A LYS 17 -84.56 -72.55 15 A HYP 21 -45.18 164.62 15 A HYP 27 -56.16 102.69 16 A PRO 5 -34.98 -38.27 16 A HYP 7 -84.76 39.95 16 A ASN 8 -172.31 -52.11 16 A CYS 14 -89.90 35.08 16 A HYP 21 -55.93 170.67 16 A ARG 26 -77.53 -160.91 16 A HYP 27 -60.49 94.84 17 A CYS 2 -113.31 -116.77 17 A CYS 3 -150.64 -90.25 17 A ASN 8 -135.64 -104.80 17 A ALA 9 -90.89 -81.07 17 A CYS 14 -114.76 64.45 17 A HYP 21 -42.58 159.78 17 A ARG 26 -86.37 -150.20 18 A CYS 2 -115.26 65.80 18 A PRO 5 -38.10 -30.75 18 A HYP 7 -87.64 34.73 18 A ASN 8 -170.52 -53.02 18 A ALA 10 -118.73 64.27 18 A CYS 14 -117.67 56.01 18 A LYS 17 -91.20 -62.67 18 A HYP 21 -45.38 164.33 18 A HYP 27 -51.94 107.40 Solution Conformation of alphaA-Conotoxin EIVA 1 N N A HYP 21 A HYP 21 HELX_P A ARG 26 A ARG 26 1 1 6 disulf 1.992 A CYS 2 A SG CYS 2 1_555 A CYS 16 A SG CYS 16 1_555 disulf 2.001 A CYS 3 A SG CYS 3 1_555 A CYS 11 A SG CYS 11 1_555 disulf 1.982 A CYS 14 A SG CYS 14 1_555 A CYS 24 A SG CYS 24 1_555 covale 1.372 both A TYR 6 A C TYR 6 1_555 A HYP 7 A N HYP 7 1_555 covale 1.353 both A HYP 7 A C HYP 7 1_555 A ASN 8 A N ASN 8 1_555 covale 1.373 both A HIS 12 A C HIS 12 1_555 A HYP 13 A N HYP 13 1_555 covale 1.352 both A HYP 13 A C HYP 13 1_555 A CYS 14 A N CYS 14 1_555 covale 1.369 both A ARG 20 A C ARG 20 1_555 A HYP 21 A N HYP 21 1_555 covale 1.373 both A HYP 21 A C HYP 21 1_555 A HYP 22 A N HYP 22 1_555 covale 1.345 both A HYP 22 A C HYP 22 1_555 A TYR 23 A N TYR 23 1_555 covale 1.370 both A ARG 26 A C ARG 26 1_555 A HYP 27 A N HYP 27 1_555 covale 1.346 both A HYP 27 A C HYP 27 1_555 A SER 28 A N SER 28 1_555 covale 1.325 both A GLY 30 A C GLY 30 1_555 A NH2 31 A N NH2 31 1_555 TOXIN Alpha-HELIX, TWO DISULFIDE BONDS, C-TERM AMIDATION, TOXIN A GLY 1 A GLY 1 14 A CYS 2 A CYS 2 5.50 CXVA_CONER UNP 1 1 P58782 GCCGPYPNAACHPCGCKVGRPPYCDRPSGG 1 30 1PQR 1 30 P58782 A 1 1 30 1 PRO modified residue HYP 7 1PQR A P58782 UNP 7 7 1 PRO modified residue HYP 13 1PQR A P58782 UNP 13 13 1 PRO modified residue HYP 21 1PQR A P58782 UNP 21 21 1 PRO modified residue HYP 22 1PQR A P58782 UNP 22 22 1 PRO modified residue HYP 27 1PQR A P58782 UNP 27 27 BINDING SITE FOR RESIDUE NH2 A 31 A NH2 31 Software 1 A GLY 30 A GLY 30 1 1_555